portindigo.blogg.se - Premier diagnostics and rhode island

#PREMIER DIAGNOSTICS AND RHODE ISLAND PLUS#
#PREMIER DIAGNOSTICS AND RHODE ISLAND PROFESSIONAL#
#PREMIER DIAGNOSTICS AND RHODE ISLAND FREE#

His findings showed the combination of HE4 and CA 125 provided the highest level sensitivity and specificity out of all marker combinations for predicting the presence of ovarian cancer. Moore published results of a pilot study in the journal of Gynecologic Oncology evaluating nine potential biomarkers and the ability of multiple marker combinations to predict the risk for ovarian cancer in women. However, CA 125 alone lacks the sensitivity required for the detection of ovarian cancer prompting researchers to look at the ability of combinations of biomarkers to predict the presence of ovarian cancer. "Our research is aimed at identifying patients at high risk for harboring an ovarian cancer so that they receive the right care from the right physician."Ĭurrently, CA 125 is the only blood test that can be used to help predict a woman's risk for ovarian cancer and to help with the clinical management of the disease. Moore notes that fewer than half of all ovarian cancer patients have their initial surgery performed by a gynecologic oncologist or surgeon with specialized training in the management of ovarian cancer. "The problem is that current methods for distinguishing benign ovarian tumors from malignant ones are limited and as a result, women must undergo surgery without an accurate assessment as to their risk for having ovarian cancer prior to their surgery."ĭr. "Roughly 20 percent of women will be diagnosed with an ovarian cyst or tumor at some point in their life, and only a small percentage of these women will be diagnosed with ovarian cancer," said Lead Researcher Richard Moore, M.D., assistant professor at The Warren Alpert Medical School of Brown University and a gynecologic oncologist in the Program in Women's Oncology at Women & Infants' Hospital of Rhode Island. Researchers say testing women suspected of having ovarian cancer for a combination of proteins, or biomarkers in the blood called HE4 and CA 125, could be the key to predicting a woman's risk for the disease dubbed the "silent killer." Currently there is no adequate diagnostic test for ovarian cancer.

#PREMIER DIAGNOSTICS AND RHODE ISLAND PROFESSIONAL#

Premier Dealers have professional heating consultants on staff to answer questions and provide professionally designed solutions for each application, which means a system will be designed for your specific needs and lifestyle.Newswise - The results of a study recently presented at the Society of Gynecologic Oncology's 39th Annual Meeting on Women's Cancer offer a promising development on the path toward better management of ovarian cancer.

#PREMIER DIAGNOSTICS AND RHODE ISLAND FREE#

Premier Dealers use combustion analyzers for the most accurate settings and tune-up, which means your system will maintain its high efficiency and quiet, trouble free operation.

Premier Dealers continually participate in training for all employees to provide them with up to date service and installation knowledge and techniques, which means you will have highly knowledgeable and skilled technicians installing and servicing your system.

#PREMIER DIAGNOSTICS AND RHODE ISLAND PLUS#

Premier Dealers have installed a minimum of 20 System 2000®, Ascent™ Combi, Ascent™ Plus Combi, Resolute™, or Accel CS™ boilers per year and have many years of experience with all Energy Kinetics’ heating systems, which means they know your system inside and out.Premier Dealers provide 24 Hour Service which means they are there if you need them.